Fredman Rafi, Wu Cindy, Rapolti Mihaela, Luckett Daniel, Fine Jason, McGuire Kandace, Gallagher Kristalyn, Roughton Michelle
Division of Plastic and Reconstructive Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Aesthet Surg J Open Forum. 2019 Feb 27;1(1):ojz006. doi: 10.1093/asjof/ojz006. eCollection 2019 Mar.
Direct-to-implant (DTI) breast reconstruction provides high-quality aesthetic results in appropriate candidates. Most commonly, implants are placed in the subpectoral space which can lead to pain and breast animation. Surgical and technological advances have allowed for successful prepectoral implant placement which may eliminate these trade-offs.
Here we present early outcomes from 153 reconstructions in 94 patients who underwent prepectoral DTI. We sought to determine whether these patients have less postoperative pain and narcotic use than subpectoral implant or expander placement.
A retrospective review was performed for all prepectoral DTI reconstructions at our institution from 2015 to 2016. Data were collected on postoperative pain and narcotic use while in hospital.
The average follow-up time was 8.5 months (range, 3-17 months) and the overall complication rate was 27% ( = 41) with the most common complications being skin necrosis (9%, = 13) and infection (7%, = 11). No statistically significant difference in complications was found in patients who underwent postmastectomy radiation therapy. Patients who underwent prepectoral DTI reconstruction did not have a statistically significant difference in postoperative pain and narcotic use while in-hospital compared with other techniques.
Prepectoral DTI reconstruction provides good results with similar complication rates to subpectoral techniques. Prepectoral DTI eliminates the problem of breast animation. Although our series did not reach statistical significance in pain scores or requirement for postoperative narcotics, we believe that it is an important preliminary result and with larger numbers we anticipate a more definitive conclusion.
直接植入式(DTI)乳房重建术能为合适的患者带来高质量的美学效果。最常见的做法是将植入物置于胸肌下间隙,这可能导致疼痛和乳房活动。手术和技术的进步使得胸肌前植入物放置成功,这可能消除这些权衡。
在此,我们展示了94例接受胸肌前DTI的患者153次重建的早期结果。我们试图确定这些患者术后疼痛和麻醉药物使用是否少于胸肌下植入物或扩张器放置。
对2015年至2016年在我们机构进行的所有胸肌前DTI重建进行回顾性研究。收集住院期间术后疼痛和麻醉药物使用的数据。
平均随访时间为8.5个月(范围3 - 17个月),总体并发症发生率为27%(n = 41),最常见的并发症是皮肤坏死(9%,n = 13)和感染(7%,n = 11)。接受乳房切除术后放疗的患者并发症无统计学显著差异。与其他技术相比,接受胸肌前DTI重建的患者住院期间术后疼痛和麻醉药物使用无统计学显著差异。
胸肌前DTI重建效果良好,并发症发生率与胸肌下技术相似。胸肌前DTI消除了乳房活动的问题。虽然我们的系列研究在疼痛评分或术后麻醉药物需求方面未达到统计学显著性,但我们认为这是一个重要的初步结果,随着样本量增加,我们期待得出更明确的结论。